Transphorm Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018
Revenue	16.51	24.05	11.37	11.93	1.36
Revenue Growth (YoY)	-31.35%	111.50%	-4.72%	778.79%	-
Cost of Revenue	17.46	12.53	6.68	6.49	4.6
Gross Profit	-0.95	11.52	4.69	5.44	-3.24
Selling, General & Admin	18.92	14.76	12.5	9.22	9.3
Research & Development	8.91	6.66	5.58	8.15	9.35
Operating Expenses	27.83	21.42	18.09	17.36	18.65
Operating Income	-28.78	-9.9	-13.4	-11.92	-21.9
Interest Expense / Income	0.73	0.79	0.76	0.76	0.71
Other Expense / Income	1.09	-0.45	3.75	2.61	3.19
Pretax Income	-30.6	-10.24	-17.91	-15.28	-25.8
Net Income	-30.6	-10.24	-17.91	-15.28	-25.8
Shares Outstanding (Basic)	56	46	32	28	4
Shares Outstanding (Diluted)	56	46	32	28	4
Shares Change	22.08%	45.11%	12.74%	567.21%	-
EPS (Basic)	-0.54	-0.22	-0.56	-0.54	-6.11
EPS (Diluted)	-0.54	-0.22	-0.56	-0.54	-6.11
Free Cash Flow	-33.33	-20.33	-14.17	-12.49	-18.02
Free Cash Flow Per Share	-0.59	-0.44	-0.45	-0.44	-4.27
Gross Margin	-5.75%	47.90%	41.24%	45.60%	-238.81%
Operating Margin	-174.29%	-41.15%	-117.82%	-99.87%	-1612.30%
Profit Margin	-185.32%	-42.56%	-157.50%	-128.06%	-1899.71%
Free Cash Flow Margin	-201.89%	-84.54%	-124.64%	-104.68%	-1326.73%
EBITDA	-28.33	-8.6	-16.31	-13.31	-23.71
EBITDA Margin	-171.61%	-35.76%	-143.47%	-111.52%	-1746.24%
Depreciation & Amortization	1.53	0.84	0.84	1.22	1.37
EBIT	-29.87	-9.44	-17.15	-14.53	-25.09
EBIT Margin	-180.90%	-39.26%	-150.81%	-121.71%	-1847.42%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).